期刊文献+

盐酸氟西汀与盐酸多塞平对治疗血管性抑郁症的对照研究 被引量:2

A comparative study of fluoxetine and doxepin in the treatment for vascular depression
下载PDF
导出
摘要 目的:探讨盐酸氟西汀与盐酸多塞平对治疗血管性抑郁症的疗效和安全性。方法:将70例血管性抑郁症患者随机分为盐酸氟西汀治疗组(35例)和盐酸多塞平治疗组(35例),疗程均为4周,用汉密尔顿抑郁量表(HAMD)和不良反应量表(TESS)分别评定评定疗效及不良反应。结果:治疗4周后,两组抗抑郁疗效显效率分别为85.7%、84.8%,与治疗前比较差异均有统计学意义(P<0.05);两组间HAMD评分比较差异无统计学意义(P>0.05);治疗后第2、4周末两组不良反应比较:盐酸多塞平组明显高于盐酸氟西汀组,比较差异有统计学意义(P<0.05)。结论:盐酸氟西汀和盐酸多塞平改善血管性抑郁患者抑郁症状的疗效相近;用盐酸氟西汀治疗血管性抑郁症的患者,安全性高,依从性好。 Objective To investigate the efficacy and security offiuoxetine and doxepin in the treatment for vascular depression.Methods 70 patients with vascular depression were divided into fluoxetine treatment group(n=35) and doxepin treatment group(n=35) randomly for 4 weeks’respective cure.HAMD and TESS were used to evaluate the efficacy and side effects respectively.Results 4 weeks after treatment,the antidepression efficacy rate of the two groups were 85.7%and 84.8%with great significance compared with those before treatment(P〈0.05) ;intergroup HAMD scores did not show any significance(P〉0.05) ;2 weeks and 4 weeks after treatment,doxepine treatment group had more side effects thanfiuoxetine treatment group with great significace(P〈0.05) .Conclusion The efficacy offiuoxetine and doxepin in the treatment for vascular depression is almost equal,whilefiuoxetine shows higher security and better efficacy.
出处 《吉林医学》 CAS 2010年第33期5948-5950,共3页 Jilin Medical Journal
关键词 氟西汀 多塞平 血管性抑郁症 Fluoxetine Doxepin Vascular depression
  • 相关文献

参考文献9

  • 1王新法,王振英,马振武.氟西汀联合利培酮治疗抑郁症的对照研究[J].临床心身疾病杂志,2004,10(3):169-171. 被引量:15
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001:75-77.
  • 3张明圆.精神科评定量表手册[M].长沙:湖南科学技术出版社,1993.34-41.
  • 4Helen C Kales,Daniel F Maixner,Alan M Mellow.Cerebrovascular disease and late-life depression[J].Am J Geriatr Psychiatry,2005,13(1):88-98.
  • 5PS Sachdev,W Wen,H Christensen,et al.White matter hypeintensities are related to physical disability and poor motor function[J].J Neurosurg Phychiatry,2005,76(1):362-367.
  • 6Rolhschild AJ,Balcs KS,Bochringer KL,et al.Olanzapine response in psycholic depression[J].J Clin Psychialry,1999,60(2):116-118.
  • 7Krishnan KRR,Hays JC,Blazer DG.MRZ-defined vascular depression[J].Am J Psychiatry,1997,154(4):497.
  • 8于欣,许滨,田运华,沈渔村.老年期情感障碍的临床特点及随访研究[J].中国心理卫生杂志,1997,11(5):276-278. 被引量:33
  • 9李根华.脑卒中后的抑郁症[J].国外医学(脑血管疾病分册),1996,4(1):22-24. 被引量:156

二级参考文献5

  • 1Rothschild AJ. Management of psychotic, treatment-resistant depression[J]. Psychiatr Clin North Am, 1996, 19:237
  • 2Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder[J]. J Clin Psychiatry, 1995,56: 423
  • 3Ostroff RB. Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression[J].J Clin Psychiatry, 1999,60: 256
  • 4沈渔邨.精神病学(第4版)[M].北京:人民卫生出版社,2003.68-69.
  • 5刘文庭,杨长虹,郭华,尤海峰.万拉法新与氟西汀治疗抑郁症对照研究[J].临床心身疾病杂志,2004,10(1):11-12. 被引量:23

共引文献984

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部